作为未来产业之一，生物制造是科技创新和产业创新融合发展的重要赛道。 清华大学主办的2025中国生物制造科技创新论坛9月25日在湖南常德开幕。 工业和信息化部消费品工业司司长何亚琼表示，中国的生物制造产业总规模已经将近1万亿，中国的发酵产能占全世界70%以上，包括湖北、湖南在内的一 批有竞争力的生物制造产业集聚区已经成长起来。但行业还存在着高质量数据和算法模型有待提升等问题。 清华大学副校长王宏伟在论坛上表示，生物制造是科技创新和产业创新融合发展的重要领域，具备引领第四次工业革命的潜力，将会带来重构传统制造业的 生产模式，替代传统天然产物的获取方式，颠覆传统农业的种养殖模式等一系列重大变革。 王宏伟谈到，据预测，2050年生物制造有望创造30万亿美元的经济价值，占全球制造业的1/3。当前，我国生物制造领域已经进入技术突破和产业化加速的 关键阶段，还需要各方共同努力，加强核心技术攻关，提升要素配置水平，构建友好应用环境。 常德作为湖南生物制造产业的重要基地，发展势头强劲。2024年，常德市合成生物制造企业35家实现产值125亿元，今年1-8月产值增长24.01%，利尔生物、 鸿健生物、引航生物等重点企业产值分别增 ...

中国生物制造产业总规模接近万亿元 中新社湖南常德9月25日电 (记者 刘育英)2025中国生物制造科技创新论坛25日在湖南常德举行。中国工 业和信息化部消费品工业司司长何亚琼在会上表示，中国生物制造产业总规模已将近1万亿元人民币， 下一步将做好生物制造顶层设计。 何亚琼表示，2025年政府工作报告第一次把生物制造作为未来产业正式提出，生物制造在中国产业板块 里已经处在非常重要的引领位置。 据他介绍，中国的发酵产能占全世界70%以上，包括湖北、湖南在内，一批有竞争力的生物制造产业集 聚区已经成长起来。与此同时，生物制造产业也面临一些挑战，如高质量数据和算法模型有待提升、中 试服务平台体系建设相对滞后等。 针对这些挑战，工信部近期遴选发布了16项人工智能在生物制造领域应用典型案例，组织开展了生物制 造标志性产品、生物制造中试平台遴选发布，生物反应器揭榜挂帅等工作。 本文为转载内容，授权事宜请联系原著作权人 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 来源：中国新闻网 编辑：王永乐 广告等商务 ...

中国的发酵产能占全世界70%以上。 2025年政府工作报告明确提出，建立未来产业投入增长机制，培育生物制造等未来产业。 聚焦生物制造热点领域和重要课题，工业和信息化部近日遴选发布了16项人工智能在生物制造领域应用典型案例，组织开展了生物制造标志性产品、生物制 造中试平台遴选发布，生物反应器揭榜挂帅等工作。 清华大学副校长王宏伟在论坛上表示，生物制造是科技创新和产业创新融合发展的重要领域，具备引领第四次工业革命的潜力，将会带来重构传统制造业的 生产模式，替代传统天然产物的获取方式，颠覆传统农业的种养殖模式等一系列重大变革。 王宏伟谈到，据预测，2050年生物制造有望创造30万亿美元的经济价值，占全球制造业的1/3。当前，我国生物制造领域已经进入技术突破和产业化加速的 关键阶段，还需要各方共同努力，加强核心技术攻关，提升要素配置水平，构建友好应用环境。 常德作为湖南生物制造产业的重要基地，发展势头强劲。2024年，常德市合成生物制造企业35家实现产值125亿元，今年1-8月产值增长24.01%，利尔生物、 鸿健生物、引航生物等重点企业产值分别增长103.9%、101.1%、48.3%，跑出了产业发展"加速度"。 ...

Core Viewpoint - The launch of D-allulose by COFCO Group marks a significant advancement in China's high-end functional sugar market and breaks international technological monopolies in the field of biological manufacturing [1][2]. Group 1: Product Launch and Market Impact - COFCO Group, through its subsidiaries, has introduced the first domestically produced D-allulose product, filling a gap in the high-end functional sugar market in China [1]. - D-allulose is recognized as a promising sugar substitute, with a sweetness level approximately 70% that of sucrose but only 10% of its calories, making it suitable for various food applications [1]. - The global D-allulose market is projected to reach $14.77 million in 2024, with a compound annual growth rate (CAGR) exceeding 14% from 2025 to 2034 [1]. Group 2: Industry and Health Implications - The introduction of D-allulose aligns with national public health initiatives, such as the "Weight Management Year," providing essential support for the Healthy China strategy [2]. - The product opens new innovation opportunities in low-sugar tea and baking industries, allowing consumers to enjoy healthier sweetness without compromising taste [2]. Group 3: Technological Advancements and Research - COFCO Group has invested significantly in research and development, successfully developing high-performance D-allulose-3-epimerase after extensive trials and genetic modifications [2]. - The company has established a comprehensive patent portfolio related to the biological synthesis of D-allulose, covering production strains, enzyme preparations, and separation processes, with 10 core patents already authorized [2][3]. - COFCO Group's commitment to technological innovation is reflected in its strategic initiatives, including policies that incentivize research and development as a core part of its business strategy [3].

Group 1 - Henan has established itself as a crucial grain production area, focusing on food security and enhancing crop yields through technology and management [1][3] - The province has developed a diversified food supply system, with significant production in oilseeds, edible fungi, and livestock, leading to the establishment of 18 industrial chains [3][25] - Henan's food industry has evolved from being a grain storage hub to a significant player in the global food market, producing a variety of products including traditional and emerging snacks [5][10] Group 2 - The production of spicy strips in Henan has reached over 10 billion packages annually, supported by 75,000 tons of high-quality wheat flour [10][12] - The establishment of wheat industrial alliances has ensured stable raw material supply for food companies, enhancing their market confidence [12][14] - The province is transitioning from primary processing to deep processing in the food industry, with government support for technological advancements [16][19] Group 3 - The Central Plains Food Laboratory has become a key driver of innovation, collaborating with enterprises to develop healthier food processing techniques [19][22] - Henan produces a significant portion of various food products in China, including half of the country's ham sausages and three-fifths of dumplings [25] - The province is enhancing its meat processing capabilities and implementing modern cold chain logistics for meat products [29][31] Group 4 - New food products like spicy strips and tea beverages are gaining popularity, with some brands expanding internationally [33][35] - The government is facilitating brand promotion and consumer engagement through various activities and logistics improvements [35][38] - The number of large-scale agricultural processing enterprises in Henan has reached 6,103, with plans for further technological integration in the food sector [38]

据证券时报报道，9月23日，中粮生物科技、中粮营养健康研究院联合研发生产的国内首个D-阿洛酮糖 产品在北京正式发布上市。中粮集团此次推出的阿洛酮糖产品不仅填补了国内高端功能糖市场的空白， 更标志着我国在生物制造领域打破国际技术垄断。 点评：D-阿洛酮糖作为代糖，广泛应用于饮料、烘焙、乳制品等领域。3月23日，中国食品科学技术学 会食品营养与健康分会发布《D-阿洛酮糖的科学共识》称，D-阿洛酮糖低能量且不升血糖，是一种具 有产业应用潜力的天然甜味物质，可作为食品添加糖的代替品，且其安全性已经得到广泛认可，多国均 已批准在食品中使用。 百龙创园：是国内首家具备工业化生产阿洛酮糖的企业。 保龄宝：是国内最早布局阿洛酮糖项目的企业之一，公司目前有超5000吨在运行产能，2025年3月启动 产能扩建，根据不同产品结构，预计26年达到3万吨产能。 *免责声明：文章内容仅供参考，不构成投资建议 *风险提示：股市有风险，入市需谨慎 根据Global Market Insight数据，2024年全球D-阿洛酮糖市场规模已达1.47亿美元，预计2025-2034年期 间将以14%的年复合增长率快速增长。7月2日，国家卫生健康委、 ...

Core Insights - The launch of D-allulose by COFCO Group marks a significant breakthrough in China's high-end functional sugar sector, filling a gap in the domestic market and supporting the health transformation of the food industry [1][2] - D-allulose, a low-calorie sugar alternative, is expected to see substantial market growth, with a projected global market size of $14.77 million in 2024 and a compound annual growth rate exceeding 14% from 2025 to 2034 [1][2] Company Developments - COFCO Group has established a comprehensive patent portfolio in the biosynthesis of D-allulose, with 17 patents covering production strains, enzyme preparations, separation processes, and overall production technology, of which 10 core patents have been authorized [2] - The company has developed a one-stop application solution and differentiated supply capabilities across various sectors, including beverages, baking, dairy, and confectionery, to accelerate the domestic application of D-allulose [2] Industry Impact - The introduction of D-allulose aligns with national public health initiatives, such as the "Weight Management Year," providing significant industrial support for the Healthy China strategy [2] - COFCO Group's commitment to innovation is reflected in its establishment of a dedicated technology innovation department and policies aimed at enhancing R&D investment and sharing benefits with researchers, fostering a collaborative ecosystem for the health food industry [3]

9月23日，由中粮集团旗下中粮生物科技、中粮营养健康研究院联合研发生产的国内首个D-阿洛酮糖产 品在北京正式发布。 作为中国最大的农粮食品企业，中粮集团敏锐洞察消费者趋势，开展战新产业（300832）布局。2017年 起，中粮集团旗下中粮生物科技、中粮营养健康研究院启动专项攻关，从498个基因库中筛选改造，历 经上千次突变体试验，最终突破性开发出高性能D-阿洛酮糖-3-差向异构酶，并于2023年获批国内首款 该酶类食品加工用酶制剂，打破了技术壁垒对D-阿洛酮糖产能的制约。 "经过8年科研攻关与系统性布局，这款健康代糖的甜蜜滋味终于可以抵达国人的舌尖。"中粮营养健康 研究院生物技术中心主任王小艳表示，"我们将加速推进生物制造技术在食品领域的深度开发，让国民 健康红利持续释放。" 截至目前，中粮集团已在生物法合成阿洛酮糖方面完成系统的专利布局，涵盖生产菌种、酶制剂、分离 工艺及整体生产工艺等17项专利，其中10项核心专利已获授权，并形成了产业化的成套技术与装备体 系，构建起覆盖饮料、烘焙、乳品、糖果等多元场景的"一站式应用解决方案"与"差异化供应能力"，为 D-阿洛酮糖在国内的加速应用提供了有力支撑。 这颗小小的 ...

Core Viewpoint - The bio-manufacturing industry is entering a new phase of accelerated development characterized by clear policies, specific support, and close integration with the real economy [7]. Policy Developments - The National Development and Reform Commission (NDRC) has emphasized the importance of bio-manufacturing as a key part of light industry upgrades, particularly in sectors such as plastic products, textiles, food and beverages, household chemicals, cosmetics, leather, and paper industries [6]. - The recent announcement from the Ministry of Industry and Information Technology highlights support for bio-based, biodegradable materials, and bio-manufacturing industries as part of the "Light Industry Growth Stabilization Work Plan (2025-2026)" [6]. Industry Transformation - Bio-technology is driving a systematic transformation of the light industry from a "resource-consuming" and "cost-competitive" model to a new paradigm focused on green, intelligent, and high-end development through raw material revolution, process innovation, functional upgrades, and supply chain security [6]. Economic Integration - The government is guiding localities to develop new growth engines such as artificial intelligence and bio-manufacturing, focusing on the integration of these technologies into traditional industries to enhance productivity and innovation [4].

Core Insights - The event "Biomanufacturing Leading the Future" was successfully held in Hefei as part of the 2025 World Manufacturing Conference, attracting over 230 participants from various sectors [1][3] - The focus was on the biomanufacturing industry, discussing key common links and development hotspots, and aiming to create a comprehensive biomanufacturing ecosystem [3][4] Industry Development - Anhui Province has established a comprehensive biomanufacturing industry system covering six sectors: biopharmaceuticals, bio-food, bio-energy, biomaterials, biochemistry, and enzyme preparations [3] - The province has developed three billion-level industry clusters in biopharmaceuticals, bio-food, and bio-energy, with leading companies like Huaheng Bio and Fengyuan Group [3][4] - A 3 billion yuan biomanufacturing industry fund has been established through cooperation between central and local governments [3] Strategic Initiatives - Hefei is integrating biomanufacturing into its new industrial cluster system, forming a dedicated task force and implementing supportive policies [4] - The establishment of the Synthetic Biology Innovation Research Institute and the Hefei (Changfeng) Synthetic Biomanufacturing Industrial Park aims to create a nationally influential biomanufacturing hub [4] Collaborative Efforts - Key projects and funds were signed during the event, including the Synthetic Biology Multiscale Incubation Center and AI-driven biomanufacturing platforms [4] - The establishment of the Anhui Biomanufacturing Industry Alliance will facilitate the gathering of innovative resources and promote the commercialization of research outcomes [7] Future Outlook - Anhui plans to optimize its industrial layout and enhance collaboration among government, industry, academia, research, finance, and services to foster a "four-chain integration" industrial ecosystem [8]